Sputnik V was already approved in Russia when it had not yet passed all clinical tests.
A study sheds light on how effective vaccination protects against corona.
Sputnik V is the world's first approved corona vaccine: On August 11, 2020, Russian President Vladimir Putin announced the emergency approval of the preparation in the media.
Emergency approval because the vaccine developed and produced in Russia has not yet completed clinical phase III *.
In this, several thousand to tens of thousands of volunteers are vaccinated in order to find out how effective and tolerable a vaccination actually is.
Sputnik V is currently being tested in clinical phase III.
Russian scientists have now published an interim analysis.
Sputnik V is not only vaccinated in Russia.
According to
the
world
,
the Russian vaccine
is already being used
in 15 countries
- although it has not yet proven itself in all clinical tests.
In Germany, too, the discussion is getting louder about allowing more vaccines in order to enable citizens to have earlier vaccination appointments.
However, there are strict rules in the European Union as to when a vaccine may be vaccinated.
A product can only be approved for the general public after phase III has been successfully completed.
This phase has not yet been completed in the case of the Sputnik V vector vaccine, but there are initial reports of the product's effectiveness in phase III.
In the journal
The Lancet
, Russian scientists came
to the conclusion that Sputnik V was 91.6 percent effective.
The researchers had tested 20,000 volunteers to see how well the vaccination protects against corona and what side effects can occur.
Sputnik V 91.6 percent effective, Biontech and Moderna vaccinations 95 and 96 percent
With 91.6 percent effectiveness, Sputnik V is at the level of effectiveness that was also shown with the Biontech and Moderna preparations.
The
Biontech preparation was proven to be up to 95 percent effective and the Moderna vaccine to be 96 percent effective
, as reported by the Tagesschau, citing the US FDA.
What is meant by these numbers is that, depending on the preparation,
91.6, 95 or 96 percent fewer corona diseases per 100 study participants
occurred
in people in the vaccinated group
than in the non-vaccinated group.
Also read
: Death shortly after the corona vaccination: people really died from it.
Vaccination with Sputnik V: These side effects are possible
Researchers from the National Research Center for Epidemiology and Microbiology, which is based at the Russian Ministry of Health
, also report serious side effects in only a few cases, according to
the
world
.
However, these were not due to the vaccination, it said
.
In most cases, the volunteers reported only mild side effects such as flu-like symptoms after vaccination.
In addition
, the study published
in the
Lancet
states
: "
Four deaths were reported during the study (three of 16,427 participants in the vaccine group and one of 5,435 participants in the placebo group)
, none of which were considered to be vaccine-related".
The study has not yet been completed,
according
to the
world
report
, a total of
40,000 volunteers will be vaccinated.
(jg) * Merkur.de is part of the Germany-wide Ippen digital editorial network
.
More sources: https://www.pharmazeutische-zeitung.de/was-steckt-hinter-dem-russischen-impfstoff-119526/;
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00191-4/fulltext
Survey on the subject of corona lockdown
Read more
: Corona vaccination for children too?
What parents need to know now.
The life-saving prick: These risk groups should be vaccinated against the flu
The life-saving prick: These risk groups should be vaccinated against the flu
List of rubric lists: © Ruben Paratore / dpa
